How CDMOs Can Support Nanoparticles for Gene Therapy, Immuno-Oncology, and Vaccines

Article

Many CDMOs outsource their nanoparticle supply chain, but in house manufacturing of nanoparticles at CDMOs is anticipated to create new market opportunities.

Related Content
© 2024 MJH Life Sciences

All rights reserved.